Actin-resistant DNAse I Expression From Oncolytic Adenovirus Enadenotucirev Enhances Its Intratumoral Spread and Reduces Tumor Growth
Spread of oncolytic viruses through tumor tissue is essential to effective virotherapy. Interstitial matrix is thought to be a significant barrier to virus particle convection between "islands" of tumor cells. One way to address this is to encode matrix-degrading enzymes within oncolytic v...
Main Authors: | Tedcastle, A, Illingworth, S, Brown, A, Seymour, L, Fisher, K |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2016
|
Similar Items
-
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
by: Dyer, A, et al.
Published: (2016) -
Preclinical safety studies of enadenotucirev, a chimeric group B human-specific oncolytic adenovirus
by: Illingworth, S, et al.
Published: (2017) -
Oncolytic Group B Adenovirus Enadenotucirev Mediates Non-apoptotic Cell Death with Membrane Disruption and Release of Inflammatory Mediators
by: Arthur Dyer, et al.
Published: (2017-03-01) -
A phase 1 dose escalation study of the oncolytic adenovirus enadenotucirev, administered intravenously to patients with epithelial solid tumors (EVOLVE)
by: Machiels, JP, et al.
Published: (2019) -
Factors responsible for inhibition of adenovirus infection by cellular debris and tumour lysate
by: Tedcastle, A, et al.
Published: (2011)